Multiple Causes of Cardiotoxic Effects in Patients With Chronic Myeloid Leukemia-Reply.
Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
Jonathan
J
Douxfils
Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
Hélène
H
Haguet
Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
Jean-Michel
JM
Dogné
D066126:Cardiotoxicity / Q000209:etiology / Q000473:pathology; D018376:Cardiovascular Abnormalities / Q000139:chemically induced / Q000503:physiopathology*; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
D000068877:Imatinib Mesylate